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INTRODUCTION
There is a propitious belief that a potent 
vaccine against the SARS- COV-2 virus is a 
panacea for the COVID-19 pandemic. The 
need for a potent vaccine is heightened as 
many nations are finding it counterproduc-
tive to sustain national lockdowns and indi-
viduals are becoming complacent with their 
hygiene and social (physical) distancing 
practices. Currently, there are more than 100 
COVID-19 vaccine candidates under develop-
ment, with a number of these in the human 
trial phase. It is suggested that the introduc-
tion of a COVID-19 vaccine will prevent the 
loss of US$375 billion to the global economy 
every month.1 There is a scientific consensus 
that the only way toeradicate the pandemic will 
be to vaccinate all people worldwide.2 To this 
end, the United Nations General Assembly 
calls for ‘the rapid scaling up of manufac-
turing and establishment of supply chains that 
promote and ensure fair, transparent, equi-
table, efficient and timely access to drugs and 
future COVID-19 vaccines’.3 Consequently, 
at this moment, global health and political 
discourse related to the COVID-19 pandemic 
are dominated by COVID-19 vaccine develop-
ment, production and distribution.
Regarding the vaccine distribution, there 
are many proposals on the table for the 
ethical distribution between countries.4 
There is a continuum of positions regarding 
the acquisition of COVID-19 vaccines. To 
one extreme is vaccine nationalism, whereby 
governments sign agreements with pharma-
ceutical manufacturers to supply their popu-
lations with vaccines ahead of the vaccines 
becoming available for other countries.5 
On the other extreme is the global access to 
COVID-19 vaccine through fair distribution 
underpinned by the notion of global public 
good—impacting residents of more than one 
country, even if not necessarily the whole 
world.6 Many countries display a mix of 
both, first trying to secure vaccines for their 
populations but also doing their share in 
terms of helping to ensure that vaccines are 
available to the most vulnerable everywhere. 
The Access to COVID-19 Tools Accelerator, 
a global collaboration, seeks to accelerate 
the development, production and equi-
table access to COVID-19 tests, treatments 
and vaccines,1 with the vaccine pillar being 
managed through the COVID-19 Vaccines 
Global Access (COVAX) Facility. Through 
the COVAX platform, countries are encour-
aged to sign up to a deal that will ensure that 
they receive a portion of the anticipated 2 
Summary box
 ► As the world struggles to contain the COVID-19 pan-
demic, different countries are increasingly focused 
on the protection of their citizens and are neglect-
ing their obligations and commitments to protecting 
asylum seekers, refugees and foreign- born migrants 
living within their borders.
 ► The vulnerabilities of asylum seekers, refugees and 
foreign- born migrants have exacerbated during the 
COVID-19 pandemic, consequently, they are more 
likely to suffer the physical and mental health and 
socioeconomic consequences of COVID-19. Such 
disproportionate impact warrants them to be con-
sidered a most- at- risk population.
 ► Structures and mechanisms and migrant- aware pol-
icies should be put in place both globally and within 
different countries to ensure that this population is 
not left behind in the COVID-19 vaccine narratives 
and considerations.
 ► We argue that countries that get COVID-19 Vaccines 
Global Access (COVAX) vaccines should also explic-
itly include asylum seekers and refugees in their ‘at- 
risk populations’, to get the vaccines.
 ► Also, the International Organization for Migration and 
civil society organisations such as Médecins sans 
Frontières should get sufficient COVAX vaccines and 
establish mechanisms to ensure the timely vaccina-
tion of this population.
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billion doses of vaccines that will be available by the end 
of 2021.
According to the WHO’s COVID-19 vaccine allocation 
mechanisms document, access to a vaccine at its incep-
tion would be aimed at protecting healthcare workers 
and the most- at- risk in a bid to mitigate the public health 
and economic impacts of the pandemic.1 The general 
COVID-19 literature has consistently identified people 
with chronic comorbidities as a most- at- risk popula-
tion, while the literature on migration in the context of 
COVID-19 has also identified asylum seekers, refugees 
and foreign migrants as a most- at- risk population owing 
to their existing vulnerabilities.7 8 Worst still, asylum 
seekers, refugees and foreign- born migrants are most 
likely to suffer from the consequences of COVID-19 as 
their conditions continue to worsen in refugee camps 
around the world,9 thus increasing their risk.
The understanding on how COVAX works is that 
the WHO will develop a framework through which the 
COVAX Facility will ensure the equitable distribution of 
the COVID-19 vaccine doses to help protect the most- at- 
risk—greater chances of being infected with COVID-19 
or of getting very sick—groups in all participating coun-
tries. In this way, it is understood that healthcare workers 
and older citizens and people living with comorbidities 
will be given priority. The question, therefore, is to what 
extent will asylum seekers, refugees and foreign migrants 
who through their increased vulnerabilities and potential 
of being impacted by COVID-19 be considered as a most- 
at- risk population, thus prioritised for vaccination?
CENTRAL ARGUMENT
With the number of COVID-19- related deaths reaching 
the 1 million mark and affecting every geographical 
region globally, the COVID-19 vaccine must be treated as 
a global public good.10 Nevertheless, as the world strug-
gles to contain COVID-19, different countries are increas-
ingly focused on the protection of their citizens and are 
neglecting their obligations and commitments to protect 
asylum seekers, refugees and foreign- born migrants living 
within their borders. For instance, although countries 
like England considered accommodating unsuccessful 
asylum seekers at the start of the COVID-19 pandemic, 
these unsuccessful asylum seekers where being evicted 
from their Home Office provided accommodations 
during the second wave of the COVID-19 pandemic, 
an act which makes no sense in either humanitarian or 
public health terms.11 Also, despite international mari-
time laws dictating a ‘duty to rescue’ refugees and asylum 
seekers in distress at sea, search- rescue- disembarkation 
operations in the Mediterranean have been brought to 
a halt.12 These structural xenophobic tendencies, and 
more, are further manifested in the lack of engage-
ment and consideration of this population in coun-
tries’ economic, poverty and hunger alleviation schemes 
during the national lockdown measures.7
Although COVID-19, disproportionately, has a greater 
impact on certain populations, asylum seekers, refu-
gees and foreign- born migrants usually find themselves 
in comparatively worse positions of vulnerability.7 The 
COVID-19 vulnerabilities are usually an extrapolation of 
already existing vulnerabilities: weakened social support 
structures, bleak socioeconomic prospects, unequal 
access to healthcare and social services, precarious 
housing conditions, tenuous living and working condi-
tions, and higher risks of exploitation and abuse.8 13 14 
These vulnerabilities have exacerbated in the context of 
the COVID-19 pandemic as they are living in crowded 
refugee camps and deportation centres with little or no 
resources and opportunities to practise personal hygiene 
and social (physical) distancing, in addition to dimin-
ished access to food and healthcare services.7 15 16 Those 
among the general population live in informal/illegal 
situations in urban slums having issues with access to 
basic health facilities owing to insecurity and crime that 
prevail in these informal settlements.
A few countries have taken steps to accommodate 
asylum seekers and refugees at the start of the COVID-19 
pandemic. For instance, Portugal temporarily granted all 
asylum seekers and foreign- born migrants full citizenship 
rights to remove the structural barriers to access to health-
care services.17 In Germany, the COVID-19 pandemic 
acted as a catalyst to mobilise solidarity and support 
for the plight of refugees.18 In England, the thousands 
of asylum seekers who were refused were provided with 
accommodation by the Home Office at the start of the 
COVID-19 outbreak.11 Nevertheless, many other coun-
tries have persisted with policies that exclude asylum 
seekers, refugees and foreign- born migrants from critical 
services while also continuing with deportations during 
the worldwide travel bans.7 17
Based on the way asylum seekers, refugees and foreign- 
born migrants were treated during the national lock-
down implemented to curb the spread of the pandemic, 
there is little chance that this population will be consid-
ered for immunisation when the vaccine reaches the 
borders of various countries. Reflecting on this in light 
of ongoing discourse on the political stakes of migration 
governance, in South Africa for instance, we observe 
that the COVID-19 response revealed little change in 
the government’s agenda to deal with asylum seekers, 
refugees and other migrants.19 This reticence to include 
asylum seekers, refugees and foreign migrants in policies 
and mechanisms to address the COVID-19 pandemic is 
further fuelled by xenophobic tendencies.7 19 According 
to Reidy,17 some governments are likely to take advantage 
of the COVID-19 crisis to push through legally dubious, 
hardline migration policies that cannot be justified by 
public health concerns. The glaring absence of migration- 
aware and mobility- competent policies is likely going to 
reduce the level of engagement of asylum seekers, refu-
gees and foreign migrants in the national fight against 
the COVID-19 pandemic and thus reducing their consid-
eration for a COVID-19 vaccine.
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At the global level, currently, COVAX envisages setting 
aside a small buffer of about 5% of the total number of 
available doses that will be reserved to build a stockpile 
to help with acute outbreaks and to support humani-
tarian organisations, for example, to vaccinate refugees 
who may not otherwise have access.20 The WHO EURO 
outlines current best practice, evidence and knowledge 
to support policy and programme development for the 
vaccination of refugees and migrants,21 which could be 
used to guarantee COVID-19 vaccine coverage in this 
population group. Unfortunately, these bestpractices 
and policies have not been dependably considered. 
We, therefore, concur with Severoni and Bartovic22 
that future efforts need to build on existing structures 
and resources to bolster coordination and prepare a 
blueprint for future emergency vaccine distribution in 
a manner that considers asylum seekers, refugees and 
migrants equitably.
The International Organization for Migration and 
civil society organisations (CSO) are strategically placed 
to contribute to discussions and decisions around the 
scale- up and equitable access to COVID-19 vaccines espe-
cially representing the interests of asylum seekers, refu-
gees and foreign migrants. Nevertheless, it appears their 
representation and engagement in the structure and 
processes of Gavi—the Coalition for Epidemic Prepared-
ness Innovations—is based on Gavi’s inadequate appre-
ciation and distrust of what CSOs do and can bring to 
Gavi’s operations.23 Owing to pressure from CSOs, Gavi 
and WHO are seeking representative CSOs to partici-
pate in COVAX.24 If CSOs are better represented in the 
COVAX governance mechanism, there is a chance that 
they will be better placed to represent the interests of 
asylum seekers, refugees and foreign migrants efficiently.
Although governments will be the initial recipients 
of the COVID-19 vaccines, fair distribution within each 
country must reflect a moral concern for the ultimate 
recipients and should be guided by the following three 
principles: (1) benefiting people and limiting harm, 
(2) prioritising the disadvantaged, and (3) equal moral 
concern.25 This ‘fair priority model’, proposed by 
Emanuel et al,25 accommodates asylum seekers, refu-
gees and foreign migrants more explicitly as it priori-
tises the disadvantaged. In this approach, Emanuel 
et al25 propose that a fair allocation of the COVID-19 
vaccine requires distributing the first doses to those 
population segments where it is possible to save the 
greatest number of life years, then considering also the 
disability that can be prevented by the vaccine and the 
amount of poverty and aggregate economic damage 
the vaccine can prevent, and finally distributing the 
vaccine to reduce transmission rates as far as possible. 
A truly ethical proposal toward the COVID-19 vaccine 
distribution should accommodate asylum seekers, refu-
gees and foreign migrants, treating all people equally 
and helping them get vaccines when they cannot do so 
on their own. This position is contrary to the notion of 
accepting inequality in access as an unchangeable fact; 
bypassing the poor to help the rich, the vulnerable to 
help the strong.4
At this stage, there is the recognition that the first 
useful vaccines to emerge may be in short supply, and 
approved vaccines will initially be made available to a 
tightly targeted 3% of the population of COVAX partici-
pating countries, then building over time to 20% of each 
country’s most vulnerable population.26 While decisions 
on the distribution of vaccines initially supplied under the 
COVAX scheme will remain at each nation’s discretion, 
countries are advised that they should use the initial 3% 
of their vaccines to focus initially on reducing mortality 
and protecting the health system—vaccinating health-
care and social workers.26 In the same way, the other 20% 
of the vaccines allocated for the country’s most vulner-
able population will be at the discretion of the country 
to manage. After everybody has received the 20%, the 
vaccine would be distributed according to other criteria, 
such as country vulnerability and the immediate threat of 
COVID-19.20 Although it is often politically untenable to 
consider refugees and asylum seekers when it comes to 
the planning of vaccination campaigns of this nature,22 
following this proposed distribution protocol, we argue 
that asylum seekers, refugees and foreign migrants should 
be considered during the 20% distribution point as they 
fit the bill of a vulnerable population. The point is that 
there is a need to include and prioritise refugees, asylum 
seekers and foreign migrants in all COVID-19 vaccina-
tion programmes, regardless the source of the vaccine, to 
successfully eliminate the pandemic within the national 
borders and indeed globally.
CONCLUSION
Whether COVID-19 vaccines are obtained through equi-
table distribution to all participating countries or through 
vaccine nationalism, it is unclear what policies, princi-
ples and mechanisms are in place to ensure that asylum 
seekers, refugees and foreign migrants are not left behind 
even though they are a vulnerable population. The call, 
therefore, is for advocacy groups and international 
organisations working with asylum seekers, refugees and 
foreign migrants to advocate for this group of people 
not to be left behind in the fight against the COVID-19 
pandemic. The COVID-19 vaccine offers CSOs, interna-
tional bodies and various governments an opportunity to 
reform and address some critical questions about access 
to COVID-19 vaccines for asylum seekers, refugees and 
foreign migrants.
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